Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3789424 | 0.89 | LMNA (0.56) | CYP3A4LMNAACHEALDH1A1KMT2A | |
| SCHEMBL9501468 | 0.86 | MAOB (0.55) | CYP3A4LMNAACHEALDH1A1KMT2A | |
| SCHEMBL249305 | 0.85 | LMNA (0.76) | CYP3A4LMNAACHEALDH1A1KMT2A | |
| SCHEMBL17028900 | 0.85 | LMNA (0.76) | CYP3A4LMNAACHEALDH1A1KMT2A | |
| SCHEMBL7753277 | 0.83 | CYP3A4 (0.54) | CYP3A4LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL1756084 | 0.83 | CYP3A4 (0.50) | CYP3A4LMNAACHEALDH1A1KMT2A | |
| SCHEMBL27592748 | 0.83 | CYP3A4 (0.50) | CYP3A4LMNAACHEALDH1A1KMT2A | |
| SCHEMBL3788510 | 0.83 | LMNA (0.48) | CYP3A4LMNAACHEALDH1A1CYP19A1 | |
| SCHEMBL20425429 | 0.82 | CYP3A4 (0.52) | CYP3A4LMNAALDH1A1KMT2AMEN1 | |
| SCHEMBL4267736 | 0.82 | MEN1 (0.76) | CYP3A4LMNAALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| CN-114773827-B | Soft polyurethane foam plastic | 湖北新嘉源工贸有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-117164745-A | Composite material for microporous membrane, composite ion exchange membrane and application of composite material | 国家电投集团氢能科技发展有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-117126311-A | Polymer, composite, ion exchange membrane and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-116808842-B | Modified microporous membrane, composite ion exchange membrane, and preparation methods and applications thereof | 国家电投集团氢能科技发展有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116808842-A | Modified microporous membrane, composite ion exchange membrane, and preparation methods and applications thereof | 国家电投集团氢能科技发展有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-103495340-B | The method of SOx in compound alcamines solution removal gas | BEIJING BOYUAN HENGSHENG HIGH-TECHNOLOGY CO.,LTD. (CN) | 2015-11-18 | — | — | CN | claimed |
| US-9012603-B2 | Peptides that block the binding of IgG to FcRn | BIOGEN IDEC HEMOPHILIA INC. (US) | 2015-04-21 | — | — | US | claimed |
| CN-103495340-A | Method of removing SOx in gas by compound alkanolamine solution | BEIJING BOYUAN HENGSHENG HIGH TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | claimed |
| US-20110059889-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn | SYNTONIX PHARMACEUTICALS, INC. | 2011-03-10 | — | — | US | claimed |
| CN-101808514-A | bioactive aniline copolymers | AUCKLAND UNISERVICES LTD | 2010-08-18 | — | — | CN | claimed |
| CN-1268604-C | Industrial preparation method for 3-amino phenylacetic acid | UNIV EAST CHINA SCIENCE & TECH (CN) | 2006-08-09 | — | — | CN | claimed |
| CN-1681470-A | Agent for dyeing keratinous fibres | HENKEL KGAA (DE) | 2005-10-12 | — | — | CN | claimed |
| CN-1634871-A | Industrial preparation method for 3-amino phenylacetic acid | UNIV EAST CHINA SCIENCE & TECH (CN) | 2005-07-06 | — | — | CN | claimed |
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | disclosed |
| CN-114773827-B | Soft polyurethane foam plastic | 湖北新嘉源工贸有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-117164745-A | Composite material for microporous membrane, composite ion exchange membrane and application of composite material | 国家电投集团氢能科技发展有限公司 | 2023-12-05 | — | — | CN | disclosed |
| WO-1996016077-A2 | REAGENT FOR QUANTIFYING FREE AMINE GROUPS | AGOURON PHARMACEUTICALS, INC. (US) | 1996-05-30 | — | — | WO | disclosed |
| CN-1122577-A | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | DU PONT MERCK PHARMA (US) | 1996-05-15 | — | — | CN | disclosed |
| CN-1075717-A | Benzodiazepine * derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1993-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059889-A1 | PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn | FCGRT, FCGR3B, FCGR1A | CYP3A4 4291/4885LMNA 4348/4885ACHE 4425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.